FR3316M - New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin. - Google Patents

New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.

Info

Publication number
FR3316M
FR3316M FR959163A FR959163A FR3316M FR 3316 M FR3316 M FR 3316M FR 959163 A FR959163 A FR 959163A FR 959163 A FR959163 A FR 959163A FR 3316 M FR3316 M FR 3316M
Authority
FR
France
Prior art keywords
arthritic
rheumatic
treatment
new drug
infectious origin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR959163A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL122978D priority Critical patent/NL122978C/xx
Priority to BE657319D priority patent/BE657319A/xx
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR959163A priority patent/FR3316M/en
Priority to FR966962A priority patent/FR1512324A/en
Priority to DE19641468892 priority patent/DE1468892B1/en
Priority to NL6414704A priority patent/NL6414704A/xx
Priority to BR16542864A priority patent/BR6465428D0/en
Priority to DK622064A priority patent/DK112236B/en
Priority to SE1542164A priority patent/SE318274B/xx
Priority to CH1636164A priority patent/CH436282A/en
Priority to GB51833/64A priority patent/GB1087729A/en
Priority to IL2270964A priority patent/IL22709A/en
Application granted granted Critical
Publication of FR3316M publication Critical patent/FR3316M/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR959163A 1964-01-02 1964-01-02 New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin. Active FR3316M (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
NL122978D NL122978C (en) 1964-01-02
BE657319D BE657319A (en) 1964-01-02
FR959163A FR3316M (en) 1964-01-02 1964-01-02 New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR966962A FR1512324A (en) 1964-01-02 1964-03-11 New esters in 21 of cortisone derivatives and method of preparation
DE19641468892 DE1468892B1 (en) 1964-01-02 1964-12-15 Process for the production of steroid-21-apocamphan-1-carboxylates with local anti-inflammatory effect
BR16542864A BR6465428D0 (en) 1964-01-02 1964-12-17 PROCESS OF PREPARATION OF NEW ESTERS IN 21-PREGNANIC DERIVATIVES
NL6414704A NL6414704A (en) 1964-01-02 1964-12-17
DK622064A DK112236B (en) 1964-01-02 1964-12-18 Analogous process for the preparation of anti-inflammatory 21-apocamphan-1-carboxylic acid esters of 17α, 21-dihydroxy-Δ <4> -pregne-3,20-diones.
SE1542164A SE318274B (en) 1964-01-02 1964-12-18
CH1636164A CH436282A (en) 1964-01-02 1964-12-18 Process for the preparation of new 21-esters of pregnanic derivatives
GB51833/64A GB1087729A (en) 1964-01-02 1964-12-21 Novel pharmacologically active steroid compounds of the pregnane series, processes for their preparation, and pharmaceutical compositions containing them
IL2270964A IL22709A (en) 1964-01-02 1964-12-31 21-esters of pregnane derivatives and a process for their preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR959163A FR3316M (en) 1964-01-02 1964-01-02 New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR966962A FR1512324A (en) 1964-01-02 1964-03-11 New esters in 21 of cortisone derivatives and method of preparation

Publications (1)

Publication Number Publication Date
FR3316M true FR3316M (en) 1965-05-17

Family

ID=26205184

Family Applications (2)

Application Number Title Priority Date Filing Date
FR959163A Active FR3316M (en) 1964-01-02 1964-01-02 New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR966962A Expired FR1512324A (en) 1964-01-02 1964-03-11 New esters in 21 of cortisone derivatives and method of preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR966962A Expired FR1512324A (en) 1964-01-02 1964-03-11 New esters in 21 of cortisone derivatives and method of preparation

Country Status (10)

Country Link
BE (1) BE657319A (en)
BR (1) BR6465428D0 (en)
CH (1) CH436282A (en)
DE (1) DE1468892B1 (en)
DK (1) DK112236B (en)
FR (2) FR3316M (en)
GB (1) GB1087729A (en)
IL (1) IL22709A (en)
NL (2) NL6414704A (en)
SE (1) SE318274B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1439605A (en) * 1972-07-14 1976-06-16 Akzo Nv 2beta-hydroxy-3-alpha-amino-steroids and derivatives thereof and the processes for their preparation

Also Published As

Publication number Publication date
BR6465428D0 (en) 1973-08-07
SE318274B (en) 1969-12-08
NL122978C (en)
NL6414704A (en) 1965-07-05
DE1468892B1 (en) 1970-03-12
CH436282A (en) 1967-05-31
DK112236B (en) 1968-11-25
FR1512324A (en) 1968-02-09
IL22709A (en) 1969-02-27
BE657319A (en)
GB1087729A (en) 1967-10-18

Similar Documents

Publication Publication Date Title
FR3244M (en) New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR1187M (en) New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin.
FR3316M (en) New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR2969M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR37M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR16M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
FR2810M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR186M (en) New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR3641M (en) New drug in particular for the treatment of states of adynamia.
FR1982M (en) New n-substituted alkanamides-hydrazines, which can be used in particular in the treatment of persistent staphylococcal infections.
FR2805M (en) New drug in particular for the treatment of affections of bacterial origin.
FR1484M (en) New drug in particular for the treatment of inflammatory manifestations of microbial origin.
FR1764M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1804M (en) New drug in particular for the treatment of infections of microbial origin.
FR2656M (en) New drug, in particular for the treatment of chronic or postprandial hyperlipemia.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR3881M (en) Medicament useful in particular for the treatment of tuberculosis.
FR2684M (en) Pharmaceutical composition for the local treatment of rheumatic pain.